Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- In Exubera's Shadow: Generex Bets Oral Spray Is Next Big Thing for Diabetics
- As companies bail out of the inhaled insulin business -- most recently Pfizer, which lost $2.8 billion before throwing Exubera overboard -- one small firm believes there is an alternative to pills, injections and inhalers. Generex, a Worcester, Mass.-based company, believes there's an opportunity for insulin delivery...
- Blog posts 2008-09-26
Additional Resources
- Critical Diabetes Test -- A1C -- Proven to Be Accurate Average Glucose
- A mathematical relationship between the average glucose level over the preceding three months and levels of the A1C test , thus yielding translation of the A1C for reporting as estimated average glucose eAG, was proven in an international study published online today in the August issue of Diabetes...
- Research articles 2008-06-07
- On World Diabetes Day, Diabetes Community Rallies Around the Importance of Knowing and Lowering A1C Levels
- ALEXANDRIA, Va., Nov. 14 /U.S. Newswire/ -- The American Diabetes Association today announced its support for the goals and messages of "Aim, Believe, Achieve -- The Diabetes A1C Initiative," an effort sponsored by the American Association of Diabetes Educators, the International Diabetes Center, and Taking Control of Your Diabetes. ...
- Research articles 2002-11-14
- ACC safety salutes superior performance
- EIGHTH AIR FORCE Maj Mark Hopson Capt Keegan McConaughey 1Lt Scott Graves Capt Chris Young SSgt Robert Howard SSgt Philip Thompson MSgt Derek Ronning A1C Nicholas Brown A1C Michael Masys A1C Jeremiah Gardner A1C Corey Miller 55th Wing...
- Research articles 2008-01-01
- Amylin Pharmaceuticals, Inc. Q4 2007 Earnings Call Transcript
- Question-and-Answer Session[Operator Instructions]. Your first question comes from the line of CoryKasimov with JPMorgan. Please proceed with your question. CoryKasimov - JPMorgan Great. Good afternoon thanks for taking the question. First of all on exenatide once-weekly and regulatory situation there. What exactly would you need to demonstrate, approve to...
- Earnings calls 2008-01-28
- EnteroMedics Inc. Business Update Call Transcript
- Question-and-Answer SessionOperator Operator Instructions Your first question comes from Mike Weinstein of JP Morgan. Mike Weinstein - JP Morgan Let’s start off by spending a minute on the additional clinical work that you’re going to be doing over the next several months and...
- Earnings calls 2008-09-26
- Most Important Diabetes Test May Be Reported in New Units
- To: NATIONAL EDITORSContact: Diane Tuncer, +1-703-299-5510, or Elizabeth Magsig, +1- 703-549-1500, ext. 2146, both of American Diabetes Association, NEWS ROOM, June 22 - 26, 2007, Room E270, McCormick Place Convention Center, +1-312-949-3210, fax, +1-312-949-3218 CHICAGO, June 25 /PRNewswire-USNewswire/ -- The preliminary results from an international study showing the relationship between...
- Research articles 2007-06-25
- ADVISORY/Leading Advocacy And Medical Organizations Launch New Initiative To Help New York Residents With Diabetes Aim For, Believe In, And Achieve Optimal Blood Sugar Control
- News/Assignment Editors & Health/Medical Writers ADVISORY...for Thursday (Nov. 14) --BUSINESS WIRE WHAT: Today in New York, and in 16 major cities nationwide, a new program called Aim. Believe. Achieve: The Diabetes A1C ...
- Research articles 2002-11-13
- Fitch Rates HarborView Mortgage Loan Trust 2005-15
- NEW YORK -- Fitch rates HarborView Mortgage Loan Trust 2005-15 mortgage loan pass-through certificates as follows: -- $874.2 million class 1-A1A, 1-A1B, 2-A1A through 2-A1C, 3-A1A through 3-A1C, PO-1, PO-2, PO-3A, PO-3B, PO-B and A-R 'AAA'; -- $16.1 million class B-1 'AA+'; -- $14.6 million class B-2...
- Research articles 2005-10-31
- Fitch Rates HarborView Mortgage Loan Trust 2005-16
- NEW YORK -- Fitch rates HarborView Mortgage Loan Trust 2005-16 mortgage loan pass-through certificates as follows: -- $1.513 billion classes 1 A1A, 1 A1B, 2 A1A, 2 A1B, 2 A1C, 3 A1A, 3 A1B, 3 A1C, 4-A1A, 4-A1B, X-1, X-2, X-3, X-4, X-B, PO-1, PO-2, PO-3, PO-4, PO-B, and...
- Research articles 2005-12-01
- RATING NEWS; MOODY'S REVISES RATING ON THE STATE OF MICHIGAN GENERAL OBLIGATION BONDS TO Aa FROM A1c
- NEW YORK--BUSINESS WIRE-- July 18, 1995 --In conjunction with the current sale of $180 million, Michigan's general obligation bond rating is now revised to Aa from A1 based upon the state's traditionally low debt levels, management's demonstrated willingness to maintain structural budget balance through conservative budgeting practices, including high levels...
- Research articles 1995-07-18
- FDA Approves JANUMET™ for Type 2 Diabetes, Offering Powerful Glucose Control of a DPP-4 Inhibitor and Metformin in a Single Tablet
- JANUMET (sitagliptin/metformin HCl) provides significantly greater A1C1 reduction than metformin alone and helped more than twice as many patients get to A1C goal
- Research articles 2007-04-02
- Medtronic Reports New Studies Confirming That Pump Therapy Improves Blood Sugar Control in Pediatric Diabetes Patients
- MINNEAPOLIS -- Insulin pump therapy improves A1C levels in three pediatric studies presented at American Diabetes Association annual meeting
- Research articles 2005-06-13
- Ships/Navy: Logistics prepositioning ships
- BRIEFING: A mix of U.S. government-owned and chartered vessels, MSC's logistics prepositioning ships LPSs are strategically located around the world to support the U.S. Navy, the Defense Logistics Agency, and the U.S. Air Force. SS Cape Jacob (T-AK 5029) carries Navy munitions and is on-site at Diego Garcia. Four LPS...
- Research articles 2003-01-01
- Diazyme Receives FDA Approval and NGSP Certification for Its Direct Enzymatic HbA1c Assay Product
- Diazyme Laboratories announced today that the U.S. Food and Drug Administration FDA has granted Diazyme 510k clearance to market its Direct Enzymatic Hemoglobin A1c (HbA1c) Assay Kit for the quantitative determination of HbA1c in human whole blood samples.
- Research articles 2007-04-20
- Lilly and Alkermes Initiate Additional Phase 3 Study for Inhaled Insulin as Part of Comprehensive Registration Program
- INDIANAPOLIS, Ind. and CAMBRIDGE, Mass. -- Eli Lilly and Company (NYSE: LLY) and Alkermes, Inc. (Nasdaq: ALKS) today announced the initiation of a Phase 3 clinical trial required for registration for their AIRR Inhaled Insulin System(1) AIR system, which is being investigated as an innovative treatment option for type 1...
- Research articles 2006-04-26
- VIVUS Inc. Q1 2008 Earnings Call Transcript
- Question-and-Answer SessionOperator Operator Instructions. And your first question comes from Corey Cosmo from JPMorgan. Please proceed. Corey Kasimov - JPMorgan Good afternoon. Thank you for taking the questions. I want to start with the upcoming Phase II data at ADA and obese diabetics and kind of start framing expectations...
- Earnings calls 2008-05-30
- CV Therapeutics Q3 2007 Earnings Call Transcript
- Question-and-Answer SessionOperator Operator Instructions. Your first question comes from the line of Mark Monane, with Needham. Mark Monane - Needham Thank you very much for taking my question, and for the thorough review of the busy quarter. Lou Lange Hi, Mark. Mark Monane - Needham A couple of questions....
- Earnings calls 2007-11-06
- CV Therapeutics, Inc. Q3 2008 Earnings Call Transcript
- Question-and-Answer SessionOperator Operator instructions Your first question is from the line of Jim Birchenough. Jim Birchenough – Barclays Capital Hi, guys, congratulations on the label expansion. Louis Lange Thank you. Jim Birchenough – Barclays Capital So, just a few questions. Number one, just wondering how you're...
- Earnings calls 2008-11-19
- Well Done Award
- The Aviation Well Done Award is presented for outstanding airmanship and professional performance during a hazardous situation and for a significant contribution to the United States Air Force Mishap Prevention Program. A1C BRADLEY RAINES 46 AMXS Eglin AFB FL An F-16 from the 85 TES was...
- Research articles 2004-07-01
- << Previous
- page 1 of 1
- Next >>
Premier Vendor Content Whitepapers, webcasts & resources from our Power Center Sponsors
